Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
4,700
Employees4,700
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
4,700
Employees4,700

MRNA Key Statistics

Market cap
90.58B
Market cap90.58B
Price-Earnings ratio
-27.30
Price-Earnings ratio-27.30
Dividend yield
—
Dividend yield—
Average volume
20.01M
Average volume20.01M
High today
$236.77
High today$236.77
Low today
$212.49
Low today$212.49
Open price
$217.27
Open price$217.27
Volume
18.78M
Volume18.78M
52 Week high
$242.29
52 Week high$242.29
52 Week low
$22.28
52 Week low$22.28

Stock Snapshot

As of today, Moderna(MRNA) shares are valued at $227.70. The company's market cap stands at 90.58B, with a P/E ratio of -27.30.

As of 2026-10-19, Moderna(MRNA) stock has fluctuated between $212.49 and $236.77. The current price stands at $227.70, placing the stock +7.2% above today's low and -3.8% off the high.

The Moderna(MRNA)'s current trading volume is 18.78M, compared to an average daily volume of 20.01M.

During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $242.29 at its peak.

During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $242.29 at its peak.

MRNA News

Benzinga 7h
What's Going On With Moderna Stock Monday?

Moderna Inc. (NASDAQ:MRNA) shares are trading higher Monday as investors position ahead of detailed Phase 3 melanoma data for its personalized cancer therapy th...

What's Going On With Moderna Stock Monday?
TipRanks 10h
Moderna price target raised to $220 from $200 at BofA

BofA raised the firm’s price target on Moderna (MRNA) to $220 from $200 and keeps a Neutral rating on the shares. With topline success of INTerpath-001 already...

Simply Wall St 21h
Moderna Stock May Still Look Stretched Despite Cancer Vaccine News

has logged very strong gains over the past year, and the sharp move now puts a spotlight on a simpler question for investors who care about valuation: Is the cu...

Moderna Stock May Still Look Stretched Despite Cancer Vaccine News

Analyst ratings

56%

of 27 ratings
Buy
22.2%
Hold
55.6%
Sell
22.2%

More MRNA News

The Motley Fool 3d
Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?

In recent years, artificial intelligence (AI) stocks soared in the triple and quadruple digits, leading the S&P 500 higher. Investors rushed to get in on the ne...

Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?
TipRanks 4d
S&P 500 Top Stock Gainers Today, 10/15/26

The S&P 500 (SPX) closed with a 0.33% return on Thursday following a hotter-than-expected Producer Price Index (PPI) print and easing Treasury yields. Healthcar...

Benzinga 4d
Nike, Moderna, Walmart Get a Lift as Traders Flee AI Stocks

Shares of Nike Inc. (NYSE:NKE), Moderna Inc. (NASDAQ:MRNA) and Walmart Inc. (NASDAQ:WMT) climbed Thursday as money flowed out of tech and AI stocks for a second...

Nike, Moderna, Walmart Get a Lift as Traders Flee AI Stocks
24/7 Wall St. 4d
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher

Investing Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher Healthcare is drawing fresh buying as money moves away from the m...

Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Simply Wall St 6d
Moderna, Why Is So Much Attention Gathering Around It?

Moderna (MRNA) just joined the NASDAQ-100 Index. This move can reshape how large institutional investors treat the stock and influence how you think about its r...

Moderna, Why Is So Much Attention Gathering Around It?
Zacks 6d
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?

Shares of Moderna (MRNA Quick QuoteMRNA - Free Report) have gained more than 5% over the past week, adding roughly $4.2 billion in market value. The upsi...

MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?
The Motley Fool 6d
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Can the pioneer of mRNA vaccines outpace the king of cystic fibrosis treatments? Choosing between Moderna (MRNA -5.00%) and Vertex Pharmaceuticals (VRTX -0.60%)...

Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.